Prescription Clinical MonographFluoroquinolone Broad-Spectrum Antibacterial
Verified Evidence Sources: openFDA & NLM MedlinePlus
Moxifloxacin Ophthalmic
Fluoroquinolones inhibit bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, preventing bacterial DNA replication and transcription.
Generic Active Chemical: Moxifloxacin Ophthalmic
Brand Formulations:MoxezaVigamox
Kitchen Food, Drink & Dietary Conflicts
Biochemical interactions with common foods, beverages & cooking ingredientsUnless your physician explicitly directs otherwise, continue your normal balanced diet while taking this medication. Maintain consistent hydration and meal intervals.
Prescription & OTC Drug Interactions (DDI)
Documented pharmacological conflicts & contraindicated co-prescriptionsNo major contraindicated drug classes listed in the basic monograph. Always provide your complete medication list to your prescribing physician.
Dietary Supplements, Herbs & Minerals (DNI)
Interactions with over-the-counter vitamins, minerals, and herbal preparationsNo acute supplement or herb contraindications identified. Notify your healthcare provider of any multi-vitamins or botanicals you take daily.
Chronotherapy & Meal Administration Protocols
Optimal absorption, meal-timing rules & GI tolerability protocolsMulti-Substance Interactive Radar
Taking Moxifloxacin Ophthalmic alongside daily coffee, supplements, or other medications?
Add all your daily medications, foods (Dairy, Spinach, Coffee, Grapefruit), and botanicals (Ashwagandha, Curcumin, Melatonin) into the SafeStack interactive engine to run full multi-way synergy collision analysis in real time.
Authoritative Clinical Evidence & Regulatory Sources
Data on this clinical monograph is compiled from the U.S. National Library of Medicine (MedlinePlus), openFDA Structured Product Labeling (SPL Section 7 Drug Interactions), the NIH Office of Dietary Supplements (ODS), and Krause and Mahan's Food & Nutrition Care Process.